Interpace Diagnostics Group Announces 1-for-10 Reverse Split

29 December 2016

Interpace Diagnostics Group, Inc. (the "Company" or "Interpace Diagnostics") (NASDAQ: IDXG), a company that provides clinically useful molecular dia